Search details
1.
Comparison of different motion correction techniques for dynamic FDG-PET/CT studies in breast cancer patients.
Q J Nucl Med Mol Imaging
; 64(4): 406-413, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-30792380
2.
Influence of mutagenic versus non-mutagenic pre-operative chemotherapy on the immune infiltration of residual breast cancer.
Acta Oncol
; 58(11): 1603-1611, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31271119
3.
Defining the design space for freeze-dried orodispersible tablets with meloxicam.
Drug Dev Ind Pharm
; 42(12): 1977-1989, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27165764
4.
Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study.
Croat Med J
; 57(2): 131-9, 2016 Apr 23.
Article
in English
| MEDLINE | ID: mdl-27106355
5.
Response evaluation after primary systemic therapy of Her2 positive breast cancer an observational cross-sectional study.
Croat Med J
; 56(2): 128-38, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25891872
6.
[Monoclonal antibody therapy in breast cancer]. / Monoklonális antitest-terápia emlõrákban.
Magy Onkol
; 57(3): 157-65, 2013 Sep.
Article
in Hungarian
| MEDLINE | ID: mdl-24107821
7.
[The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission]. / Az FDG-PET-CT szerepe az emlorák primer szisztémás kezelése során: a metabolikus változások és a patológiai remisszió összefüggései.
Orv Hetil
; 153(49): 1958-64, 2012 Dec 09.
Article
in Hungarian
| MEDLINE | ID: mdl-23204302
8.
Investigating the Prognostic Relevance of Tumor Immune Microenvironment and Immune Gene Assembly in Breast Carcinoma Subtypes.
Cancers (Basel)
; 14(8)2022 Apr 12.
Article
in English
| MEDLINE | ID: mdl-35454849
9.
Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations.
Pathol Oncol Res
; 26(2): 997-1006, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-30941738
10.
Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer.
Pathol Oncol Res
; 26(3): 1499-1510, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-31446607
11.
Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer.
Breast Cancer
; 24(1): 137-146, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-26979062
12.
Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
Diagn Pathol
; 12(1): 20, 2017 Feb 21.
Article
in English
| MEDLINE | ID: mdl-28222768
13.
Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer.
Virchows Arch
; 468(6): 675-86, 2016 Jun.
Article
in English
| MEDLINE | ID: mdl-27026269
14.
AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients.
NPJ Breast Cancer
; 2: 16033, 2016.
Article
in English
| MEDLINE | ID: mdl-28721387
15.
Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer.
Nucl Med Commun
; 36(1): 28-37, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25299471
16.
Complexity of Response Evaluation During Primary Systemic Therapy of Breast Cancer: Scoring Systems and Beyond-Preliminary Results.
Anticancer Res
; 35(9): 5063-72, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26254408
17.
Primary systemic therapy for breast cancer: Does the patient's involvement in decision-making create a new future?
Patient Educ Couns
; 98(6): 695-703, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25749023
Results
1 -
17
de 17
1
Next >
>>